Compare Stocks: ABP, CELZ, AQB, and CDIO

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABP Abpro	$0.52	$0.52	$0.52 ▼ $29.97	$1.42M	N/A	5.06 million shs	N/A
AQB AquaBounty Technologies	$1.10 +5.8%	$1.15	$0.77 ▼ $1.94	$5.66M	1.48	189,345 shs	68,412 shs
CDIO Cardio Diagnostics	$1.76 +5.4%	$1.92	$0.97 ▼ $7.91	$5.21M	2.29	1.29 million shs	27,334 shs
CELZ Creative Medical Technology	$0.82 +5.9%	$1.04	$0.62 ▼ $6.25	$5.39M	2.06	3.24 million shs	63,104 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABP Abpro	0.00%	0.00%	0.00%	0.00%	-90.84%
AQB AquaBounty Technologies	+0.48%	+12.62%	-9.57%	+7.22%	-44.39%
CDIO Cardio Diagnostics	-4.57%	-14.80%	-19.32%	-1.18%	-62.81%
CELZ Creative Medical Technology	-5.81%	-13.13%	-12.03%	-10.20%	-77.74%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABP Abpro	$0.52	$0.52	$0.52 ▼ $29.97	$1.42M	N/A	5.06 million shs	N/A
AQB AquaBounty Technologies	$1.10 +5.8%	$1.15	$0.77 ▼ $1.94	$5.66M	1.48	189,345 shs	68,412 shs
CDIO Cardio Diagnostics	$1.76 +5.4%	$1.92	$0.97 ▼ $7.91	$5.21M	2.29	1.29 million shs	27,334 shs
CELZ Creative Medical Technology	$0.82 +5.9%	$1.04	$0.62 ▼ $6.25	$5.39M	2.06	3.24 million shs	63,104 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABP Abpro	0.00%	0.00%	0.00%	0.00%	-90.84%
AQB AquaBounty Technologies	+0.48%	+12.62%	-9.57%	+7.22%	-44.39%
CDIO Cardio Diagnostics	-4.57%	-14.80%	-19.32%	-1.18%	-62.81%
CELZ Creative Medical Technology	-5.81%	-13.13%	-12.03%	-10.20%	-77.74%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABP Abpro	1.50	Reduce	N/A	N/A
AQB AquaBounty Technologies	1.00	Sell	N/A	N/A
CDIO Cardio Diagnostics	1.00	Sell	N/A	N/A
CELZ Creative Medical Technology	2.00	Hold	N/A	N/A

Current Analyst Ratings Breakdown

Latest ABP, CELZ, AQB, and CDIO Analyst Ratings

Date	Company	Brokerage	Action	Rating
9/24/2026	CELZ Creative Medical Technology	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
9/14/2026	AQB AquaBounty Technologies	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
9/10/2026	CELZ Creative Medical Technology	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
9/8/2026	CDIO Cardio Diagnostics	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (E+)
8/28/2026	AQB AquaBounty Technologies	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
8/27/2026	CELZ Creative Medical Technology	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
8/20/2026	CELZ Creative Medical Technology	Roth Capital Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy
8/13/2026	CELZ Creative Medical Technology	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
8/12/2026	AQB AquaBounty Technologies	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
7/31/2026	CELZ Creative Medical Technology	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)

(Data available from 10/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABP Abpro	N/A	N/A	N/A	N/A	($8.83) per share	N/A
AQB AquaBounty Technologies	N/A	N/A	N/A	N/A	($0.49) per share	N/A
CDIO Cardio Diagnostics	$10K	520.96	N/A	N/A	$3.82 per share	0.46
CELZ Creative Medical Technology	$3K	1,797.25	N/A	N/A	$2.04 per share	0.40

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABP Abpro	-$7.23M	-$4.23	N/A	N/A	N/A	N/A	N/A	-344.76%	N/A
AQB AquaBounty Technologies	-$18.49M	-$0.82	N/A	N/A	N/A	N/A	-147.07%	-28.73%	11/10/2026 (Estimated)
CDIO Cardio Diagnostics	-$6.50M	-$2.92	N/A	N/A	N/A	-43,133.33%	-82.28%	-76.03%	11/6/2026 (Estimated)
CELZ Creative Medical Technology	-$5.99M	-$2.07	N/A	N/A	N/A	N/A	-86.52%	-81.96%	11/6/2026 (Estimated)

Latest ABP, CELZ, AQB, and CDIO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/10/2026	N/A	AQB AquaBounty Technologies	-$1.30	N/A	N/A	N/A	$0.27 million	N/A
11/6/2026	N/A	CELZ Creative Medical Technology	-$0.24	N/A	N/A	N/A	N/A	N/A
8/7/2026	Q2 2026	CDIO Cardio Diagnostics	N/A	-$0.51	N/A	-$0.51	N/A	$0.01 million
8/7/2026	Q2 2026	CELZ Creative Medical Technology	-$0.39	-$0.41	-$0.02	-$0.41	N/A	N/A
8/6/2026	Q2 2026	AQB AquaBounty Technologies	N/A	-$0.26	N/A	-$0.32	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABP Abpro	N/A	N/A	N/A	N/A	N/A
AQB AquaBounty Technologies	N/A	N/A	N/A	N/A	N/A
CDIO Cardio Diagnostics	N/A	N/A	N/A	N/A	N/A
CELZ Creative Medical Technology	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABP Abpro	N/A	0.07	0.07
AQB AquaBounty Technologies	N/A	4.26	4.26
CDIO Cardio Diagnostics	N/A	17.16	17.16
CELZ Creative Medical Technology	N/A	12.90	12.90

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABP Abpro	23.30%
AQB AquaBounty Technologies	8.92%
CDIO Cardio Diagnostics	8.06%
CELZ Creative Medical Technology	1.42%

Insider Ownership

Company	Insider Ownership
ABP Abpro	13.70%
AQB AquaBounty Technologies	1.02%
CDIO Cardio Diagnostics	8.99%
CELZ Creative Medical Technology	1.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABP Abpro	15	2.72 million	2.34 million	N/A
AQB AquaBounty Technologies	3	5.15 million	5.10 million	No Data
CDIO Cardio Diagnostics	17	2.96 million	2.69 million	Not Optionable
CELZ Creative Medical Technology	4	6.59 million	6.53 million	Not Optionable

ABP, CELZ, AQB, and CDIO Headlines

Recent News About These Companies

Head to Head Analysis: Creative Medical Technology (NASDAQ:CELZ) versus Grifols (NASDAQ:GRFS)

September 30, 2026 | defenseworld.netD

Creative Medical Technology Expands Control of BioDefense Subsidiary

September 25, 2026 | tipranks.com

Creative Medical Expands Ultrasome Intellectual Property Portfolio

September 18, 2026 | rttnews.com

Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing

September 17, 2026 | globenewswire.com

Creative Medical Expands Authorized Shares and Warrant Exercise

August 31, 2026 | tipranks.com

Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 ...

August 20, 2026 | markets.businessinsider.com

Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning

August 20, 2026 | globenewswire.com

Creative Medical receives US patent allowance for exosome-based type 1 diabetes immunotherapy

August 6, 2026 | msn.com

Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection ...

August 6, 2026 | markets.businessinsider.com

Creative Medical Technology Stock Surges After Key Patent Win

August 6, 2026 | benzinga.com

Creative Medical Technology Holdings shares surge as traders appear to latch onto earlier pipeline updates and a tiny-float setup

August 6, 2026 | quiverquant.comQ

Creative Medical Technology Holdings Receives USPTO Notice of Allowance for Patent Covering Exosome-Based Type 1 Diabetes Treatment

August 6, 2026 | quiverquant.comQ

Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms

August 6, 2026 | globenewswire.com

Creative Medical Technology Announces Warrant Inducement Financing Agreements

July 2, 2026 | tipranks.com

Creative Medical Technology Holdings Issues Mid-Year Update

July 1, 2026 | globenewswire.com

Creative Medical Technology Holdings Announces Immediate Exercise of Warrants for Approximately $4.5 Million in Gross Proceeds

June 30, 2026 | quiverquant.comQ

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds

June 30, 2026 | globenewswire.com

Creative Medical Technology Holdings Announces FDA Clearance of Expanded ADAPT Trial Cohort for CELZ-201 in Chronic Lower Back Pain

June 22, 2026 | quiverquant.comQ

Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain

June 22, 2026 | globenewswire.com

Creative Medical Technology opens nationwide burn-pit data registry

June 16, 2026 | proactiveinvestors.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ABP, CELZ, AQB, and CDIO Company Descriptions

Abpro NASDAQ:ABP

$0.52 0.00 (0.00%)

As of 10/14/2026

Abpro Holdings Inc. is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc., formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.

AquaBounty Technologies NASDAQ:AQB

$1.10 +0.06 (+5.77%)

As of 04:00 PM Eastern

AquaBounty Technologies, Inc., a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Harvard, Massachusetts.

Cardio Diagnostics NASDAQ:CDIO

$1.76 +0.09 (+5.39%)

Closing price 04:00 PM Eastern

Extended Trading

$1.70 -0.05 (-3.13%)

As of 04:18 PM Eastern

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

Creative Medical Technology NASDAQ:CELZ

$0.82 +0.05 (+5.89%)

Closing price 04:00 PM Eastern

Extended Trading

$0.82 +0.00 (+0.51%)

As of 06:52 PM Eastern

Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease. It also develops ImmCelz, an immunotherapy platform for multiple diseases; OvaStem for treatment of female infertility; CELZ-201 to treat Type 1 diabetes; AlloStemSpine for the treatment of chronic lower back pain; and Alova to treat infertility as a result of premature ovarian failure. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ABP, CELZ, AQB, and CDIO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ABP, CELZ, AQB, and CDIO Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ABP, CELZ, AQB, and CDIO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ABP, CELZ, AQB, and CDIO Company Descriptions

Abpro NASDAQ:ABP

AquaBounty Technologies NASDAQ:AQB

Cardio Diagnostics NASDAQ:CDIO

Creative Medical Technology NASDAQ:CELZ

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ABP, CELZ, AQB, and CDIO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ABP, CELZ, AQB, and CDIO Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ABP, CELZ, AQB, and CDIO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ABP, CELZ, AQB, and CDIO Company Descriptions

Abpro NASDAQ:ABP

AquaBounty Technologies NASDAQ:AQB

Cardio Diagnostics NASDAQ:CDIO

Creative Medical Technology NASDAQ:CELZ

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools